Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06301516 · ClinicalTrials.gov registry record · Phase 1
Impact VR: An Emotion Recognition and Regulation Training Program for Youth With CD
A Phase 1 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 1
- Development phase
- 220
- Enrollment target
NCT06301516 is a Phase 1 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 220 participants.
The verdict
NCT06301516, a Phase 1 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 220 participants
- Enrollment target
Study Summary
Conduct disorder (CD) is one of the most prevalent childhood psychiatric disorders. Unfortunately, there are limited treatments available for CD. The present study aims to test an innovative virtual reality intervention called Impact VR for symptom reduction in a sample of 60 youth with CD.
Interventions
- BEHAVIORAL Virtual Reality
- OTHER Comparative Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2024-02-16 |
| Est. Completion | 2024-09-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06301516
The ClinicalTrials.gov registry entry for NCT06301516 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Virtual Reality is the first listed.
NCT06301516 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06301516 about?
NCT06301516 is a clinical study titled "Impact VR: An Emotion Recognition and Regulation Training Program for Youth With CD". Conduct disorder (CD) is one of the most prevalent childhood psychiatric disorders. Unfortunately, there are limited treatments available for CD. The present study aims to test an innovative virtual reality intervention called Impact VR for symptom reduction in a sample of 60 youth with CD.
What is the current status of trial NCT06301516?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 220 participants. The study started on 2024-02-16. Estimated completion is 2024-09-26.
What interventions are being tested in trial NCT06301516?
The interventions under investigation include: Virtual Reality (BEHAVIORAL), Comparative Control (OTHER).
Who is sponsoring clinical trial NCT06301516?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.